ÂÜÀòÂÒÂ×

Max G. Ostermeier is an accomplished entrepreneur and executive in the medical device and biotech industries, currently serving as a member of the Scientific Advisory Board at both the Leibniz Science Campus Living Therapeutic Materials and the INM-Leibniz Institute for New Materials since March 2022. As the CEO and Founder of Implandata Ophthalmic Products since January 2010, Max G. Ostermeier is focused on transforming glaucoma management for the 80 million patients at risk of permanent eyesight loss. Previous leadership roles include CEO positions at Mesotec, Odicrain, Cranium Telemetrics, and Vital Sensors GmbH/Inc., among others, showcasing a strong track record in innovation and development of medical and cardiac devices. Max G. Ostermeier also held the role of General Manager at Proligo LLC / Proligo GmbH and served as CFO at Nigu GmbH, contributing significant expertise across various sectors. Holding an MBA in Finance from Hochschule Landshut, Max G. Ostermeier has a well-rounded background that combines technical knowledge with business acumen.